Fighting hunger “requires every available approach to be successful,” Yorzyk added. HelloFresh’s culinary team tapped influencer chef Tineke “Tini” Younger, who competed on Gordon Ramsey’s Next Level ...

Recursion, Roche and Genentech unveiled the latest product of their nearly four-year artificial intelligence drug discovery collaboration. GSK ’s Blenrep was approved by the FDA for treatment of ...

Merck announced that sales of Keytruda topped more than $8 billion for the first time in a quarter, up 10% from the same period a year ago. The pharma giant also narrowed its full-year profit outlook ...

WPP has downgraded its growth guidance for 2025 to a decline of between 5.5% and 6%, with chief executive Cindy Rose describing performance as “unacceptable”.

Maine Family Planning’s closures are among the first visible signs of what leaders call the biggest setback to reproductive care in 50 years.

In its fourth year, the daylong conference touched on a number of pain points in the health media space and offered best practices for navigating these challenges.

When children and adults rarely see their own experiences reflected on screen, they miss out on validation and the chance to recognize their own strengths.

Evolvics' Oliver Nelson and Chris Tuleya sit down with MM+M's Jack O'Brien to discuss how most brands are getting media reporting wrong.

The future of DDB as a global network is in doubt as parent company Omnicom has confirmed it is carrying out a “rigorous” review of all of its agency brands. It is thought Omnicom is likely to scale ...

Speedskater Erin Jackson spoke about living with eczema. By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as ...

NRG Therapeutics made three senior appointments in newly created roles: Sarah Almond as VP of translational biology; David Brocklebank as director of clinical operations and Kathryn Oliver as director ...

A Department of Veterans Affairs memo obtained by ProPublica erects new roadblocks to care for veterans with the rare but deadly cancer. The agency cites no new science but relies on an executive ...